What FDA Concluded FDA described the chronic-insomnia evidence as inconclusive and, at best, preliminary
Your provider may recommend anti-nausea medication (ondansetron, metoclopramide) for breakthrough symptoms, or adjust your escalation schedule based on tolerability
Christensen M, Knop FK, Holst JJ, et al
Many obesity specialists view obesity as a chronic condition requiring ongoing management, similar to high blood pressure or type 2 diabetes
The study found that the use of GLP-1 analogues was associated with an elevated risk of these illnesses, as well as an increased risk of cholecystectomy
Additionally, vitamin B12 is involved in the metabolism of homocysteine, an amino acid that, when elevated, can increase the risk of cardiovascular diseases